BIOMARIN PHARMACEUTICAL INC Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for March 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 126.40 | 1,000 | 126,396 | 33,258 | 34.3 K to 33.3 K (-2.92 %) |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 124.87 | 1,000 | 124,866 | 34,258 | 35.3 K to 34.3 K (-2.84 %) |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 123.48 | 1,000 | 123,477 | 35,258 | 36.3 K to 35.3 K (-2.76 %) |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | M | 21.51 | 5,845 | 125,726 | 2,000 | |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | M | 21.51 | 34,155 | 734,674 | 0 | |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 123.57 | 41,315 | 5,105,166 | 88,635 | 130 K to 88.6 K (-31.79 %) |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | M | 21.51 | 5,845 | 125,726 | 129,950 | 124.1 K to 130 K (+4.71 %) |
| Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | M | 21.51 | 34,155 | 734,674 | 124,105 | 90 K to 124.1 K (+37.97 %) |
| Mar 17 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | A | 124.37 | 9,000 | 1,119,330 | 9,000 | |
| Mar 17 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 0.00 | 4,000 | 0 | 12,800 | 8.8 K to 12.8 K (+45.45 %) |
| Mar 17 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Option Exercise | M | 37.46 | 14,484 | 542,571 | 15,347 | |
| Mar 17 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Option Exercise | M | 26.49 | 516 | 13,669 | 2,709 | |
| Mar 17 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Sell | S | 120.87 | 15,000 | 1,813,002 | 73,846 | 88.8 K to 73.8 K (-16.88 %) |
| Mar 17 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Buy | M | 37.46 | 14,484 | 542,571 | 88,846 | 74.4 K to 88.8 K (+19.48 %) |
| Mar 17 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Buy | M | 26.49 | 516 | 13,669 | 74,362 | 73.8 K to 74.4 K (+0.70 %) |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 15,000 | 194,850 | 46,500 | |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 114.89 | 2,021 | 232,201 | 36,258 | 38.3 K to 36.3 K (-5.28 %) |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 112.14 | 4,000 | 448,574 | 38,279 | 42.3 K to 38.3 K (-9.46 %) |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 112.12 | 15,000 | 1,681,809 | 42,279 | 57.3 K to 42.3 K (-26.19 %) |
| Mar 11 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 15,000 | 194,850 | 57,279 | 42.3 K to 57.3 K (+35.48 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 51,500 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 108.36 | 90,500 | 9,806,580 | 90,500 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 113.70 | 10,000 | 1,137,016 | 42,279 | 52.3 K to 42.3 K (-19.13 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 52,279 | 42.3 K to 52.3 K (+23.65 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 39,600 | 0 | 254,757 | 215.2 K to 254.8 K (+18.41 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Option Exercise | A | 108.36 | 21,900 | 2,373,084 | 21,900 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Grant | A | 0.00 | 9,600 | 0 | 73,846 | 64.2 K to 73.8 K (+14.94 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | A | 108.36 | 23,900 | 2,589,804 | 23,900 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Grant | A | 0.00 | 10,500 | 0 | 42,090 | 31.6 K to 42.1 K (+33.24 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | A | 108.36 | 30,500 | 3,304,980 | 30,500 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 13,400 | 0 | 89,950 | 76.6 K to 90 K (+17.50 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | M | 14.39 | 3,051 | 43,904 | 0 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | M | 17.86 | 11,000 | 196,460 | 0 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | A | 108.36 | 23,900 | 2,589,804 | 23,900 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 116.37 | 14,051 | 1,635,091 | 109,700 | 123.8 K to 109.7 K (-11.35 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Buy | M | 14.39 | 3,051 | 43,904 | 123,751 | 120.7 K to 123.8 K (+2.53 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Buy | M | 17.86 | 11,000 | 196,460 | 120,700 | 109.7 K to 120.7 K (+10.03 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 10,500 | 0 | 109,700 | 99.2 K to 109.7 K (+10.58 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Option Exercise | A | 108.36 | 23,900 | 2,589,804 | 23,900 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 10,500 | 0 | 79,278 | 68.8 K to 79.3 K (+15.27 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | M | 17.33 | 10,000 | 173,300 | 12,500 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | M | 11.15 | 10,000 | 111,500 | 0 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Sell | S | 106.57 | 20,000 | 2,131,400 | 30,150 | 50.2 K to 30.2 K (-39.88 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Buy | M | 17.33 | 10,000 | 173,300 | 50,150 | 40.2 K to 50.2 K (+24.91 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Buy | M | 11.15 | 10,000 | 111,500 | 40,150 | 30.2 K to 40.2 K (+33.17 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 28.23 | 7,000 | 197,610 | 7,491 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 109.46 | 7,000 | 766,210 | 8,800 | 15.8 K to 8.8 K (-44.30 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 28.23 | 7,000 | 197,610 | 15,800 | 8.8 K to 15.8 K (+79.55 %) |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | A | 63.10 | 10,000 | 631,000 | 10,000 | |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 0.00 | 4,000 | 0 | 8,800 | 4.8 K to 8.8 K (+83.33 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Option Exercise | M | 39.06 | 15,500 | 605,430 | 39,500 | |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 107.00 | 15,500 | 1,658,500 | 68,676 | 84.2 K to 68.7 K (-18.41 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Buy | M | 39.06 | 15,500 | 605,430 | 84,176 | 68.7 K to 84.2 K (+22.57 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Option Exercise | M | 26.49 | 20,000 | 529,800 | 3,225 | |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Sell | S | 108.31 | 23,000 | 2,491,027 | 64,246 | 87.2 K to 64.2 K (-26.36 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | SVP, General Counse ... | Buy | M | 26.49 | 23,000 | 609,270 | 87,246 | 64.2 K to 87.2 K (+35.80 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 3,000 | 38,970 | 61,500 | |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 107.71 | 916 | 98,660 | 42,279 | 43.2 K to 42.3 K (-2.12 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 9.86 | 500 | 4,930 | 43,695 | 43.2 K to 43.7 K (+1.16 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 107.42 | 5,000 | 537,097 | 215,157 | 220.2 K to 215.2 K (-2.27 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 108.44 | 5,000 | 542,195 | 220,157 | 225.2 K to 220.2 K (-2.22 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 107.96 | 3,000 | 323,893 | 43,195 | 46.2 K to 43.2 K (-6.49 %) |
| Mar 04 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 3,000 | 38,970 | 46,195 | 43.2 K to 46.2 K (+6.95 %) |